scholarly article | Q13442814 |
P50 | author | Richard Bianco | Q56850060 |
P2093 | author name string | Julia Davydova | |
Lisa Koodie | |||
George Ruth | |||
Michele Dunning | |||
Malavika Chandrashekar | |||
Matthew G Robertson | |||
P2860 | cites work | Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer. | Q55004955 |
A differentiated porcine bronchial epithelial cell culture model for studying human adenovirus tropism and virulence | Q59240801 | ||
Oncolytic viruses: finally delivering | Q26772039 | ||
Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 | Q28303765 | ||
Rat membrane cofactor protein (MCP; CD46) is expressed only in the acrosome of developing and mature spermatozoa and mediates binding to immobilized activated C3 | Q28576601 | ||
The biomedical piglet: establishing reference intervals for haematology and clinical chemistry parameters of two age groups with and without iron supplementation | Q28817046 | ||
Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment | Q29615852 | ||
The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3 | Q33201422 | ||
Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster model | Q33713048 | ||
Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment | Q34327712 | ||
Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma | Q34426949 | ||
Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species | Q34545667 | ||
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. | Q34781681 | ||
Disruption of mouse CD46 causes an accelerated spontaneous acrosome reaction in sperm | Q34784569 | ||
Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review). | Q34995657 | ||
A new generation of serotype chimeric infectivity-enhanced conditionally replicative adenovirals: the safety profile of ad5/3-Δ24 in advance of a phase I clinical trial in ovarian cancer patients | Q35101968 | ||
Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach | Q35126999 | ||
Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer | Q35563005 | ||
Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus | Q35861543 | ||
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. | Q35870225 | ||
In vivo bioimaging tracks conditionally replicative adenoviral replication and provides an early indication of viral antitumor efficacy | Q36097074 | ||
Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus | Q36184357 | ||
An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector | Q36209165 | ||
New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster. | Q36209172 | ||
INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies. | Q36209205 | ||
Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors | Q36387951 | ||
Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats | Q37132217 | ||
Adenoviruses: update on structure and function | Q37352487 | ||
Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer | Q37360204 | ||
Adenovirus receptors: implications for targeting of viral vectors | Q38012560 | ||
Chapter three--Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds | Q38047472 | ||
Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans | Q38893420 | ||
Oncolytic adenoviruses: design, generation, and experimental procedures | Q39125899 | ||
Effect of increased viral replication and infectivity enhancement on radioiodide uptake and oncolytic activity of adenovirus vectors expressing the sodium iodide symporter | Q39194008 | ||
Transduction of liver metastases after intravenous injection of Ad5/35 or Ad35 vectors with and without factor X-binding protein pretreatment | Q39278465 | ||
The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F | Q39581053 | ||
CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7. | Q39612847 | ||
Growth characteristics of human adenoviruses on porcine cell lines | Q40025937 | ||
Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors. | Q40151129 | ||
Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma | Q40160544 | ||
A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. | Q40223632 | ||
Cotton rat tumor model for the evaluation of oncolytic adenoviruses. | Q40460003 | ||
Productive replication of human adenovirus type 5 in canine cells. | Q40478143 | ||
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection. | Q41706961 | ||
Restricted replication of human adenovirus type 5 in mouse cell lines | Q41759912 | ||
Functional loss of p21/Waf-1 in a case of benign canine multicentric melanoma | Q42817526 | ||
Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. | Q44486695 | ||
Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism | Q44653587 | ||
Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors | Q45114912 | ||
Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells | Q45117334 | ||
Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus | Q45600695 | ||
Infectivity-enhanced adenoviruses deliver efficacy in clinical samples and orthotopic models of disseminated gastric cancer | Q45858408 | ||
Efficient adenoviral-mediated gene delivery into porcine mesenchymal stem cells | Q45861655 | ||
Cyclooxygenase-2 promoter for tumour-specific targeting of adenoviral vectors to melanoma | Q45862588 | ||
CD46 is a cellular receptor for group B adenoviruses | Q45869560 | ||
Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses | Q45871953 | ||
Porcine toxicology studies of SCH 58500, an adenoviral vector for the p53 gene | Q45882937 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Adenoviridae | Q193447 |
animal model | Q264024 | ||
oncolytic virus | Q1560099 | ||
P304 | page(s) | 198 | |
P577 | publication date | 2019-02-08 | |
P1433 | published in | Cancers | Q27722963 |
P1476 | title | Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses | |
P478 | volume | 11 |
Search more.